The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study

NCT02793128 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Transitional Cell
Transitional Cell Carcinoma of Renal Pelvis

Interventions

DRUG: UGN-101 instillations

Sponsor

UroGen Pharma Ltd.